Identificação
Identificação pessoal
- Nome completo
- Milene Gonçalves
Nomes de citação
- Gonçalves, Milene
Identificadores de autor
- Ciência ID
- 5D14-5239-34EB
- ORCID iD
- 0000-0002-4893-1184
Telefones
- Telemóvel
-
- (351) 919517423 (Pessoal)
Domínios de atuação
- Ciências Médicas e da Saúde
Idiomas
Idioma | Conversação | Leitura | Escrita | Compreensão | Peer-review |
---|---|---|---|---|---|
Inglês | Utilizador independente (B1) | Utilizador independente (B1) | Utilizador independente (B1) | Utilizador independente (B1) | |
Português | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) |
Formação
Grau | Classificação | |
---|---|---|
2022/09/10 - 2028
Em curso
|
Integrated Master’s degree in medicine (Licenciatura)
Universidade de Coimbra - Faculdade de Medicina, Portugal
|
|
2020/09/01 - 2024/05/13
Concluído
|
Dottorato di ricerca in Medicina Clinica e Sperimentale e Medical Humanities - co-tutela (Dottorato di Ricerca)
Università degli Studi dell'Insubria, Itália
"IMMU-KYN-PARK: exploring indoleamine 2,3-dioxygenase 1 in peripheral immune system in Parkinson's disease (double PhD agreement)" (TESE/DISSERTAÇÃO)
|
|
2018/10/01 - 2024/05/13
Concluído
|
PhD Programme in Experimental Biology and Biomedicine (Doutoramento)
Especialização em Specialization in Neuroscience and Disease
Universidade de Coimbra, Portugal
"IMMU-KYN-PARK: exploring indoleamine 2,3-dioxygenase 1 in peripheral immune system in Parkinson's disease" (TESE/DISSERTAÇÃO)
|
|
2019/09/09 - 2019/09/20
Concluído
|
Advanced Course on dementia Prevention, 9th – 20th September 2019 (Outros)
Imperial College London School of Public Health, Reino Unido
|
|
2019/01/01 - 2019/01/31
Concluído
|
Animal Research and Welfare Certification (Curso de Especialização Tecnológica)
Direcção-Geral de Alimentação e Veterinária, Portugal
|
|
2012
Concluído
|
Master in Biochemistry (Mestrado)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
"Caracterização da Resposta Imune Periférica na Doença de Alzheimer" (TESE/DISSERTAÇÃO)
|
18 |
2010 - 2011
Concluído
|
English for academics (Outros)
Universidade de Coimbra Faculdade de Letras, Portugal
|
15 |
2010
Concluído
|
Biomedical Sciences (Licenciatura)
Instituto Politécnico de Coimbra Escola Superior de Tecnologia da Saúde de Coimbra, Portugal
"Prevalência da Panton Valentine-Leukocidin em Staphylococcus aureus associados a Infecções do Tracto Respiratório" (TESE/DISSERTAÇÃO)
|
17 |
Percurso profissional
Outros
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2023/05/01 - Atual | Biomedical Scientist | Serviço de Sangue e Medicina Transfusional, Centro Hospitalar e Universitário de Coimbra, Portugal |
2018/10/01 - 2023/04/30 | PhD Student fellow: 'Kynurenine pathway as a Potential Therapeutic Target in Parkinson's Disease', reference SFRH/BD/139013/2018 | Fundação para a Ciência e a Tecnologia, Portugal |
CNC.IBILI, Portugal | ||
2013/05/01 - 2018/07/16 | Biomedical scientist & Quality Manager | Laboratório de São José, Lda, Portugal |
2012/01/01 - 2012/12/31 | Researcher fellow at the project "LRRK2 role on auto-antibody production by human B cells" funded by Michael J. Fox Foundation | Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal |
2010/07/15 - 2011/09/30 | Voluntary researcher at the Immunology group of Center of Neuroscience and cell Disease grupo de Imunologia | Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal |
2010/01/15 - 2010/05/29 | Voluntary Researcher Voluntary researcher - “Allergic Inflammation” project of the Pneumonology Center of Coimbra University | Centro Hospitalar e Universitário de Coimbra EPE, Portugal |
2009/10/26 - 2009/11/20 | Biochemistry internship - Biomedical Sciences | Hospitais da Universidade de Coimbra, Portugal |
2009/09/15 - 2009/10/22 | Immunology and Virology internship - Biomedical Sciences | Instituto Português do Sangue e da Transplantação IP, Portugal |
2009/06/01 - 2009/07/01 | Haematology internship - Biomedical Sciences | Centro Hospitalar e Universitário de Coimbra EPE, Portugal |
2009/04/14 - 2009/05/14 | Haematology internship - ERASMUS mobility - Biomedical Sciences | Turku University Hospital (TYKS OS 131; TKYS 933), Finlândia |
2009/02/24 - 2009/04/03 | Microbiology internship - ERASMUS mobility - Biomedical Sciences | National Institute for Health and Welfare, Finlândia |
Projetos
Bolsa
Designação | Financiadores | |
---|---|---|
2018/10/01 - 2023/04/30 | Kynurenine pathway as a Potential Therapeutic Target in Parkinson's Disease', reference SFRH/BD/139013/2018
SFRH/BD/139013/2018
Bolseiro de Doutoramento
CNC.IBILI, Portugal
|
Concluído
|
Produções
Publicações
Artigo em revista |
|
Atividades
Apresentação oral de trabalho
Título da apresentação | Nome do evento Anfitrião (Local do evento) |
|
---|---|---|
2023 | Oral presentation: Dopamine reduces indoleamine 2,3- dyoxigenase-1 inducibility in circulating myeloid cells through b-adrenergic receptors: is this relevantin Parkinson’s Disease? | 53rd Meeting of the Portuguese Society of Pharmacology, 41st Meeting of Clinical Pharmacology and 22nd Meeting of Toxicology
Portuguese Society of Pharmacology
|
2023 | Oral presentation (PhD supervisor): SOS Salbutamol: are ß2 Adrenergic receptors druggable targets to modulate inflammation in Parkinson¿s Disease? | 1st Immune Parknet Annual Conference
(Turquia)
|
2023 | Oral presentation: Dopamine as an immunomodulator agent in Parkinson’s disease. | Annual congress of Portuguese Society of movement disorders 2023.
Portuguese Society of Movement Diseases (Portugal)
|
2023 | Oral presentation (PhD Supervisor): Evaluating the expression and activity of IDO1 in human circulating cells under a specific proinflammatory milieu: is this a possible in vitro Parkinson´s Disease model? | 2nd Immune Parknet Annual Conference
(Espanha)
|
2023 | Poster presentation (PhD supervisor): SOS Salbutamol: are ß2 receptors druggable targets to modulate inflammation in Parkinson’s Disease | 19th World Congress of Basic and Clinical Pharmacology,
British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) (Scotland - Glasgow)
|
2022 | Poster presentation: DO1 - a druggable target in immune dysregulation in Parkinson¿s Disease. | CIBB – Center for Innovative Biomedicine and Biotechnology meeting 2022 |
2022 | Oral presentation as a guest speaking : Are IDO1+myeloid cells a druggable target in Parkinson¿s Disease. | brain corner session of moving on series – what contributes to the well-being in PD?
portuguese society of neurology, Portuguese Society of Movement Diseases and BIAL.
|
2022 | Virtual poster presentation: Are IDO1+Dendritic cells a druggable target in Parkinson’s Disease? | Neuroscience meeting from Society for neuroscience 2022 |
2021 | Oral Presentation: Exploring IDO1 in PD: Immune cellular distribution and Interaction | Octave scientific journey of the PhD programme in Clinical and Experimental Medicine and Medical Humanities
University of Insubria (Insubria, Itália)
|
2020 | Oral presentation: IDO1 activation decreases T cell proliferation | Seventh scientific journey of the PhD programme in Clinical and Experimental Medicine and Medical Humanities of University
of Insubria
University of Insubria (Insubria, Itália)
|
2012/07/13 | Alterations in peripheral B Lymphocytes subsets of Mild cognitive Impairment and early stage Alzheimer’s disease patients (Poster). | Alzheimer’s Association International Conference, Vancouver 2012
(Vancouver, Canadá)
|
Distinções
Outra distinção
2018 | PhD Schoolarship - SFRH/BD/139013/2018 - Kynurenine pathway as a Potential Therapeutic Target in Parkinson's Disease
Fundação para a Ciência e a Tecnologia, Portugal
|
2010 | Merit Schoolarship 2008/2009 (Despacho nº 13531/2009 16 de Maio MCTES)
Instituto Politécnico de Coimbra, Portugal
|